Truist Financial acquires a stake in Eli Lilly, which reported strong revenue but missed EPS estimates.

Truist Financial Corp acquired a 1.4% stake in Eli Lilly and Company, owning 372,030 shares valued at $307 million. Eli Lilly reported a 45.2% year-over-year revenue growth to $12.73 billion but missed earnings per share (EPS) estimates by $1.30, with EPS at $3.34. The company's stock is valued at $779.60 per share, with a market cap of $738.85 billion. Despite missing EPS, Eli Lilly announced a quarterly dividend of $1.50 per share.